SHARON BENZENO
CIK 1780854 · Chief Commercial Ofc Imm Med · last filed 2026-03-13
SHARON BENZENO is a Chief Commercial Ofc Imm Med who has filed 35 SEC Form 4 insider transactions across 1 company since 2020. The most recent filing shows the insider sold $831.1K of ADPT on Mar 13, 2026. Across all open-market trades the lifetime net is −$26.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$4.80M
1
35
-$26.24M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ADPT | Chief Commercial Ofc Imm Med | 272,751 | $17.60 | $4.80M | -$26.24M | 35 | 2026-03-13 |
Recent Filings
35 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-13 | ADPT | Sell (S) | −63,103 | -$831.1K | EDGAR |
| 2026-03-06 | ADPT | Grant (A) | +39,063 | $0 | EDGAR |
| 2025-12-08 | ADPT | Mixed | — | -$108.5K | EDGAR |
| 2025-11-24 | ADPT | Mixed | −95,932 | -$5.68M | EDGAR |
| 2025-03-06 | ADPT | Mixed | +65,308 | -$311.8K | EDGAR |
| 2024-03-06 | ADPT | Mixed | +103,589 | -$101.0K | EDGAR |
| 2023-03-08 | ADPT | Mixed | +121,230 | -$100.7K | EDGAR |
| 2022-03-08 | ADPT | Mixed | +79,702 | -$32.1K | EDGAR |
| 2021-03-17 | ADPT | Mixed | — | -$13.5K | EDGAR |
| 2021-03-08 | ADPT | Grant (A) | +22,894 | $0 | EDGAR |